These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36322814)

  • 41. "Mummy, my eyelids are heavy": A case series of juvenile myasthenia gravis.
    Krishna L; Abdul Jalil NF; Lott PW; Singh S; Choo MM
    Eur J Ophthalmol; 2021 Mar; 31(2):NP119-NP122. PubMed ID: 31390886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Green Chemometric Determination of Cefotaxime Sodium in the Presence of Its Degradation Impurities Using Different Multivariate Data Processing Tools; GAPI and AGREE Greenness Evaluation.
    Sharaf YA; Ibrahim AE; El Deeb S; Sayed RA
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myasthenia Gravis and Its Aeromedical Implications.
    Jagathesan T; O'Brien MD
    Aerosp Med Hum Perform; 2017 Jan; 88(1):30-33. PubMed ID: 28061919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trauma-induced myasthenia gravis: coincidence or causal relationship?
    Siriratnam P; Zhang W; Faragher M
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33811091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular myasthenia presenting as progressive external ophthalmoplegia.
    Das JC; Chaudhuri Z; Bhomaj S; Sharma P; Aggarwal M
    J Pediatr Ophthalmol Strabismus; 2002; 39(1):52-4. PubMed ID: 11859920
    [No Abstract]   [Full Text] [Related]  

  • 46. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.
    Singh G; Hodgson T; Clarke DE
    Perm J; 2017; 21():15-240. PubMed ID: 28080955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of myasthenia--I.
    Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract]   [Full Text] [Related]  

  • 49. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mivacurium chloride and myasthenia gravis.
    Seigne RD; Scott RP
    Br J Anaesth; 1994 Apr; 72(4):468-9. PubMed ID: 8155454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malabsorption of pyridostigmine in patients with myasthenia gravis.
    Cohan SL; Dretchen KL; Neal A
    Neurology; 1977 Mar; 27(3):299-301. PubMed ID: 557769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Novel, Sustainable, and Eco-Friendly Spectrophotometric and Chemometric Approach for Determination of Severely Overlapped Spectrum via Unified Regression Equation: Greenness and Whiteness Assessment.
    Magdy R; Fares NV; Farouk M; Hemdan A
    J AOAC Int; 2023 Sep; 106(5):1348-1360. PubMed ID: 36924427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New diagnosis myasthenia gravis and preeclampsia in late pregnancy.
    Ozcan J; Balson IF; Dennis AT
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25721832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of pyridostigmine bromide and its metabolites in biological samples.
    Zhao B; Moochhala SM; Lu J; Tan D; Lai MH
    J Pharm Pharm Sci; 2006; 9(1):71-81. PubMed ID: 16849010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
    Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
    Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of HPLC-UV Method for Simultaneous Determination of Corticosteroid Co-Administered Immune Therapy.
    Abdelhamid NS; Farid NF; Anwar BH; Magdy MA
    J Chromatogr Sci; 2024 Jul; 62(6):554-561. PubMed ID: 37470262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Turn-On-Type Fluorescence Resonance Energy Transfer Eco-friendly Method for Nitazoxanide Quantification in Pharmaceutical Dosage Form and Spiked Plasma: Evaluation of Greenness Profile Using Different Assessment Tools.
    Mostafa EA; Elkady EF; El-Didamoony MA; Batakoushy HA
    J Fluoresc; 2023 May; 33(3):973-985. PubMed ID: 36542223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyridostigmine levels in myasthenia gravis.
    Kornfeld P; Mittag T; Genkins G; Papatestas AE; Horowitz SH
    Neurology; 1977 Nov; 27(11):1099. PubMed ID: 563008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.